Global Artemisinin Antimalarial Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Artemisinin Antimalarial Drugs Industry Forecast” looks at past sales and reviews total world Artemisinin Antimalarial Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Artemisinin Antimalarial Drugs sales for 2023 through 2029. With Artemisinin Antimalarial Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin Antimalarial Drugs industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin Antimalarial Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin Antimalarial Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artemisinin Antimalarial Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin Antimalarial Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin Antimalarial Drugs.
The global Artemisinin Antimalarial Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artemisinin Antimalarial Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artemisinin Antimalarial Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artemisinin Antimalarial Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artemisinin Antimalarial Drugs players cover Novartis, Sanofi, Ajanta, Cipla, Ipca, Guilin Medicine, GlaxoSmithKline, Mylan Labs and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Antimalarial Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Artemisinin Antimalarial Drugs market?
What factors are driving Artemisinin Antimalarial Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin Antimalarial Drugs market opportunities vary by end market size?
How does Artemisinin Antimalarial Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Artemisinin Antimalarial Drugs Industry Forecast” looks at past sales and reviews total world Artemisinin Antimalarial Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Artemisinin Antimalarial Drugs sales for 2023 through 2029. With Artemisinin Antimalarial Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin Antimalarial Drugs industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin Antimalarial Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin Antimalarial Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artemisinin Antimalarial Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin Antimalarial Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin Antimalarial Drugs.
The global Artemisinin Antimalarial Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artemisinin Antimalarial Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artemisinin Antimalarial Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artemisinin Antimalarial Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artemisinin Antimalarial Drugs players cover Novartis, Sanofi, Ajanta, Cipla, Ipca, Guilin Medicine, GlaxoSmithKline, Mylan Labs and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Antimalarial Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Artesunate
- Dihydroartemisinin
- Artemether
- Prevention
- Treatment
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sanofi
- Ajanta
- Cipla
- Ipca
- Guilin Medicine
- GlaxoSmithKline
- Mylan Labs
- Roche
What is the 10-year outlook for the global Artemisinin Antimalarial Drugs market?
What factors are driving Artemisinin Antimalarial Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin Antimalarial Drugs market opportunities vary by end market size?
How does Artemisinin Antimalarial Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Antimalarial Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Country/Region, 2018, 2022 & 2029
2.2 Artemisinin Antimalarial Drugs Segment by Type
2.2.1 Artesunate
2.2.2 Dihydroartemisinin
2.2.3 Artemether
2.3 Artemisinin Antimalarial Drugs Sales by Type
2.3.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Artemisinin Antimalarial Drugs Sale Price by Type (2018-2023)
2.4 Artemisinin Antimalarial Drugs Segment by Application
2.4.1 Prevention
2.4.2 Treatment
2.4.3 Other
2.5 Artemisinin Antimalarial Drugs Sales by Application
2.5.1 Global Artemisinin Antimalarial Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Artemisinin Antimalarial Drugs Sale Price by Application (2018-2023)
3 GLOBAL ARTEMISININ ANTIMALARIAL DRUGS BY COMPANY
3.1 Global Artemisinin Antimalarial Drugs Breakdown Data by Company
3.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2018-2023)
3.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Artemisinin Antimalarial Drugs Revenue by Company (2018-2023)
3.2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Artemisinin Antimalarial Drugs Sale Price by Company
3.4 Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Antimalarial Drugs Product Location Distribution
3.4.2 Players Artemisinin Antimalarial Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ARTEMISININ ANTIMALARIAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin Antimalarial Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Artemisinin Antimalarial Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Artemisinin Antimalarial Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Artemisinin Antimalarial Drugs Sales Growth
4.4 APAC Artemisinin Antimalarial Drugs Sales Growth
4.5 Europe Artemisinin Antimalarial Drugs Sales Growth
4.6 Middle East & Africa Artemisinin Antimalarial Drugs Sales Growth
5 AMERICAS
5.1 Americas Artemisinin Antimalarial Drugs Sales by Country
5.1.1 Americas Artemisinin Antimalarial Drugs Sales by Country (2018-2023)
5.1.2 Americas Artemisinin Antimalarial Drugs Revenue by Country (2018-2023)
5.2 Americas Artemisinin Antimalarial Drugs Sales by Type
5.3 Americas Artemisinin Antimalarial Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Antimalarial Drugs Sales by Region
6.1.1 APAC Artemisinin Antimalarial Drugs Sales by Region (2018-2023)
6.1.2 APAC Artemisinin Antimalarial Drugs Revenue by Region (2018-2023)
6.2 APAC Artemisinin Antimalarial Drugs Sales by Type
6.3 APAC Artemisinin Antimalarial Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin Antimalarial Drugs by Country
7.1.1 Europe Artemisinin Antimalarial Drugs Sales by Country (2018-2023)
7.1.2 Europe Artemisinin Antimalarial Drugs Revenue by Country (2018-2023)
7.2 Europe Artemisinin Antimalarial Drugs Sales by Type
7.3 Europe Artemisinin Antimalarial Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Antimalarial Drugs by Country
8.1.1 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type
8.3 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs
10.3 Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
10.4 Industry Chain Structure of Artemisinin Antimalarial Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Antimalarial Drugs Distributors
11.3 Artemisinin Antimalarial Drugs Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ ANTIMALARIAL DRUGS BY GEOGRAPHIC REGION
12.1 Global Artemisinin Antimalarial Drugs Market Size Forecast by Region
12.1.1 Global Artemisinin Antimalarial Drugs Forecast by Region (2024-2029)
12.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artemisinin Antimalarial Drugs Forecast by Type
12.7 Global Artemisinin Antimalarial Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Ajanta
13.3.1 Ajanta Company Information
13.3.2 Ajanta Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ajanta Main Business Overview
13.3.5 Ajanta Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Ipca
13.5.1 Ipca Company Information
13.5.2 Ipca Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ipca Main Business Overview
13.5.5 Ipca Latest Developments
13.6 Guilin Medicine
13.6.1 Guilin Medicine Company Information
13.6.2 Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Guilin Medicine Main Business Overview
13.6.5 Guilin Medicine Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Mylan Labs
13.8.1 Mylan Labs Company Information
13.8.2 Mylan Labs Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mylan Labs Main Business Overview
13.8.5 Mylan Labs Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Antimalarial Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Country/Region, 2018, 2022 & 2029
2.2 Artemisinin Antimalarial Drugs Segment by Type
2.2.1 Artesunate
2.2.2 Dihydroartemisinin
2.2.3 Artemether
2.3 Artemisinin Antimalarial Drugs Sales by Type
2.3.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Artemisinin Antimalarial Drugs Sale Price by Type (2018-2023)
2.4 Artemisinin Antimalarial Drugs Segment by Application
2.4.1 Prevention
2.4.2 Treatment
2.4.3 Other
2.5 Artemisinin Antimalarial Drugs Sales by Application
2.5.1 Global Artemisinin Antimalarial Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Artemisinin Antimalarial Drugs Sale Price by Application (2018-2023)
3 GLOBAL ARTEMISININ ANTIMALARIAL DRUGS BY COMPANY
3.1 Global Artemisinin Antimalarial Drugs Breakdown Data by Company
3.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2018-2023)
3.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Artemisinin Antimalarial Drugs Revenue by Company (2018-2023)
3.2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Artemisinin Antimalarial Drugs Sale Price by Company
3.4 Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Antimalarial Drugs Product Location Distribution
3.4.2 Players Artemisinin Antimalarial Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ARTEMISININ ANTIMALARIAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin Antimalarial Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Artemisinin Antimalarial Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Artemisinin Antimalarial Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Artemisinin Antimalarial Drugs Sales Growth
4.4 APAC Artemisinin Antimalarial Drugs Sales Growth
4.5 Europe Artemisinin Antimalarial Drugs Sales Growth
4.6 Middle East & Africa Artemisinin Antimalarial Drugs Sales Growth
5 AMERICAS
5.1 Americas Artemisinin Antimalarial Drugs Sales by Country
5.1.1 Americas Artemisinin Antimalarial Drugs Sales by Country (2018-2023)
5.1.2 Americas Artemisinin Antimalarial Drugs Revenue by Country (2018-2023)
5.2 Americas Artemisinin Antimalarial Drugs Sales by Type
5.3 Americas Artemisinin Antimalarial Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Antimalarial Drugs Sales by Region
6.1.1 APAC Artemisinin Antimalarial Drugs Sales by Region (2018-2023)
6.1.2 APAC Artemisinin Antimalarial Drugs Revenue by Region (2018-2023)
6.2 APAC Artemisinin Antimalarial Drugs Sales by Type
6.3 APAC Artemisinin Antimalarial Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin Antimalarial Drugs by Country
7.1.1 Europe Artemisinin Antimalarial Drugs Sales by Country (2018-2023)
7.1.2 Europe Artemisinin Antimalarial Drugs Revenue by Country (2018-2023)
7.2 Europe Artemisinin Antimalarial Drugs Sales by Type
7.3 Europe Artemisinin Antimalarial Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Antimalarial Drugs by Country
8.1.1 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type
8.3 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs
10.3 Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
10.4 Industry Chain Structure of Artemisinin Antimalarial Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Antimalarial Drugs Distributors
11.3 Artemisinin Antimalarial Drugs Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ ANTIMALARIAL DRUGS BY GEOGRAPHIC REGION
12.1 Global Artemisinin Antimalarial Drugs Market Size Forecast by Region
12.1.1 Global Artemisinin Antimalarial Drugs Forecast by Region (2024-2029)
12.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artemisinin Antimalarial Drugs Forecast by Type
12.7 Global Artemisinin Antimalarial Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Ajanta
13.3.1 Ajanta Company Information
13.3.2 Ajanta Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ajanta Main Business Overview
13.3.5 Ajanta Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Ipca
13.5.1 Ipca Company Information
13.5.2 Ipca Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ipca Main Business Overview
13.5.5 Ipca Latest Developments
13.6 Guilin Medicine
13.6.1 Guilin Medicine Company Information
13.6.2 Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Guilin Medicine Main Business Overview
13.6.5 Guilin Medicine Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Mylan Labs
13.8.1 Mylan Labs Company Information
13.8.2 Mylan Labs Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mylan Labs Main Business Overview
13.8.5 Mylan Labs Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Artemisinin Antimalarial Drugs Product Portfolios and Specifications
13.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artemisinin Antimalarial Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Artemisinin Antimalarial Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Artesunate
Table 4. Major Players of Dihydroartemisinin
Table 5. Major Players of Artemether
Table 6. Global Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 7. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Table 8. Global Artemisinin Antimalarial Drugs Revenue by Type (2018-2023) & ($ million)
Table 9. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2018-2023)
Table 10. Global Artemisinin Antimalarial Drugs Sale Price by Type (2018-2023) & (US$/G)
Table 11. Global Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Table 13. Global Artemisinin Antimalarial Drugs Revenue by Application (2018-2023)
Table 14. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2018-2023)
Table 15. Global Artemisinin Antimalarial Drugs Sale Price by Application (2018-2023) & (US$/G)
Table 16. Global Artemisinin Antimalarial Drugs Sales by Company (2018-2023) & (KG)
Table 17. Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2018-2023)
Table 18. Global Artemisinin Antimalarial Drugs Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2018-2023)
Table 20. Global Artemisinin Antimalarial Drugs Sale Price by Company (2018-2023) & (US$/G)
Table 21. Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution and Sales Area
Table 22. Players Artemisinin Antimalarial Drugs Products Offered
Table 23. Artemisinin Antimalarial Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Artemisinin Antimalarial Drugs Sales by Geographic Region (2018-2023) & (KG)
Table 27. Global Artemisinin Antimalarial Drugs Sales Market Share Geographic Region (2018-2023)
Table 28. Global Artemisinin Antimalarial Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Artemisinin Antimalarial Drugs Sales by Country/Region (2018-2023) & (KG)
Table 31. Global Artemisinin Antimalarial Drugs Sales Market Share by Country/Region (2018-2023)
Table 32. Global Artemisinin Antimalarial Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Artemisinin Antimalarial Drugs Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Artemisinin Antimalarial Drugs Sales by Country (2018-2023) & (KG)
Table 35. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country (2018-2023)
Table 36. Americas Artemisinin Antimalarial Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country (2018-2023)
Table 38. Americas Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 39. Americas Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 40. APAC Artemisinin Antimalarial Drugs Sales by Region (2018-2023) & (KG)
Table 41. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region (2018-2023)
Table 42. APAC Artemisinin Antimalarial Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Region (2018-2023)
Table 44. APAC Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 45. APAC Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 46. Europe Artemisinin Antimalarial Drugs Sales by Country (2018-2023) & (KG)
Table 47. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2018-2023)
Table 48. Europe Artemisinin Antimalarial Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2018-2023)
Table 50. Europe Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 51. Europe Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 52. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2018-2023) & (KG)
Table 53. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 57. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 58. Key Market Drivers & Growth Opportunities of Artemisinin Antimalarial Drugs
Table 59. Key Market Challenges & Risks of Artemisinin Antimalarial Drugs
Table 60. Key Industry Trends of Artemisinin Antimalarial Drugs
Table 61. Artemisinin Antimalarial Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Artemisinin Antimalarial Drugs Distributors List
Table 64. Artemisinin Antimalarial Drugs Customer List
Table 65. Global Artemisinin Antimalarial Drugs Sales Forecast by Region (2024-2029) & (KG)
Table 66. Global Artemisinin Antimalarial Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Artemisinin Antimalarial Drugs Sales Forecast by Country (2024-2029) & (KG)
Table 68. Americas Artemisinin Antimalarial Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Artemisinin Antimalarial Drugs Sales Forecast by Region (2024-2029) & (KG)
Table 70. APAC Artemisinin Antimalarial Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Artemisinin Antimalarial Drugs Sales Forecast by Country (2024-2029) & (KG)
Table 72. Europe Artemisinin Antimalarial Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Artemisinin Antimalarial Drugs Sales Forecast by Country (2024-2029) & (KG)
Table 74. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Artemisinin Antimalarial Drugs Sales Forecast by Type (2024-2029) & (KG)
Table 76. Global Artemisinin Antimalarial Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Artemisinin Antimalarial Drugs Sales Forecast by Application (2024-2029) & (KG)
Table 78. Global Artemisinin Antimalarial Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 81. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Sanofi Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 86. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Ajanta Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Ajanta Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 91. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 92. Ajanta Main Business
Table 93. Ajanta Latest Developments
Table 94. Cipla Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Cipla Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 96. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 97. Cipla Main Business
Table 98. Cipla Latest Developments
Table 99. Ipca Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Ipca Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 101. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 102. Ipca Main Business
Table 103. Ipca Latest Developments
Table 104. Guilin Medicine Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 106. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 107. Guilin Medicine Main Business
Table 108. Guilin Medicine Latest Developments
Table 109. GlaxoSmithKline Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 111. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Mylan Labs Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Mylan Labs Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 116. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 117. Mylan Labs Main Business
Table 118. Mylan Labs Latest Developments
Table 119. Roche Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Roche Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 121. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 122. Roche Main Business
Table 123. Roche Latest Developments
Table 1. Artemisinin Antimalarial Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Artemisinin Antimalarial Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Artesunate
Table 4. Major Players of Dihydroartemisinin
Table 5. Major Players of Artemether
Table 6. Global Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 7. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Table 8. Global Artemisinin Antimalarial Drugs Revenue by Type (2018-2023) & ($ million)
Table 9. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2018-2023)
Table 10. Global Artemisinin Antimalarial Drugs Sale Price by Type (2018-2023) & (US$/G)
Table 11. Global Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Table 13. Global Artemisinin Antimalarial Drugs Revenue by Application (2018-2023)
Table 14. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2018-2023)
Table 15. Global Artemisinin Antimalarial Drugs Sale Price by Application (2018-2023) & (US$/G)
Table 16. Global Artemisinin Antimalarial Drugs Sales by Company (2018-2023) & (KG)
Table 17. Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2018-2023)
Table 18. Global Artemisinin Antimalarial Drugs Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2018-2023)
Table 20. Global Artemisinin Antimalarial Drugs Sale Price by Company (2018-2023) & (US$/G)
Table 21. Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution and Sales Area
Table 22. Players Artemisinin Antimalarial Drugs Products Offered
Table 23. Artemisinin Antimalarial Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Artemisinin Antimalarial Drugs Sales by Geographic Region (2018-2023) & (KG)
Table 27. Global Artemisinin Antimalarial Drugs Sales Market Share Geographic Region (2018-2023)
Table 28. Global Artemisinin Antimalarial Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Artemisinin Antimalarial Drugs Sales by Country/Region (2018-2023) & (KG)
Table 31. Global Artemisinin Antimalarial Drugs Sales Market Share by Country/Region (2018-2023)
Table 32. Global Artemisinin Antimalarial Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Artemisinin Antimalarial Drugs Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Artemisinin Antimalarial Drugs Sales by Country (2018-2023) & (KG)
Table 35. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country (2018-2023)
Table 36. Americas Artemisinin Antimalarial Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country (2018-2023)
Table 38. Americas Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 39. Americas Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 40. APAC Artemisinin Antimalarial Drugs Sales by Region (2018-2023) & (KG)
Table 41. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region (2018-2023)
Table 42. APAC Artemisinin Antimalarial Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Region (2018-2023)
Table 44. APAC Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 45. APAC Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 46. Europe Artemisinin Antimalarial Drugs Sales by Country (2018-2023) & (KG)
Table 47. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2018-2023)
Table 48. Europe Artemisinin Antimalarial Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2018-2023)
Table 50. Europe Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 51. Europe Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 52. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2018-2023) & (KG)
Table 53. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2018-2023) & (KG)
Table 57. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2018-2023) & (KG)
Table 58. Key Market Drivers & Growth Opportunities of Artemisinin Antimalarial Drugs
Table 59. Key Market Challenges & Risks of Artemisinin Antimalarial Drugs
Table 60. Key Industry Trends of Artemisinin Antimalarial Drugs
Table 61. Artemisinin Antimalarial Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Artemisinin Antimalarial Drugs Distributors List
Table 64. Artemisinin Antimalarial Drugs Customer List
Table 65. Global Artemisinin Antimalarial Drugs Sales Forecast by Region (2024-2029) & (KG)
Table 66. Global Artemisinin Antimalarial Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Artemisinin Antimalarial Drugs Sales Forecast by Country (2024-2029) & (KG)
Table 68. Americas Artemisinin Antimalarial Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Artemisinin Antimalarial Drugs Sales Forecast by Region (2024-2029) & (KG)
Table 70. APAC Artemisinin Antimalarial Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Artemisinin Antimalarial Drugs Sales Forecast by Country (2024-2029) & (KG)
Table 72. Europe Artemisinin Antimalarial Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Artemisinin Antimalarial Drugs Sales Forecast by Country (2024-2029) & (KG)
Table 74. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Artemisinin Antimalarial Drugs Sales Forecast by Type (2024-2029) & (KG)
Table 76. Global Artemisinin Antimalarial Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Artemisinin Antimalarial Drugs Sales Forecast by Application (2024-2029) & (KG)
Table 78. Global Artemisinin Antimalarial Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 81. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Sanofi Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 86. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Ajanta Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Ajanta Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 91. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 92. Ajanta Main Business
Table 93. Ajanta Latest Developments
Table 94. Cipla Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Cipla Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 96. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 97. Cipla Main Business
Table 98. Cipla Latest Developments
Table 99. Ipca Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Ipca Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 101. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 102. Ipca Main Business
Table 103. Ipca Latest Developments
Table 104. Guilin Medicine Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 106. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 107. Guilin Medicine Main Business
Table 108. Guilin Medicine Latest Developments
Table 109. GlaxoSmithKline Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 111. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Mylan Labs Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Mylan Labs Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 116. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 117. Mylan Labs Main Business
Table 118. Mylan Labs Latest Developments
Table 119. Roche Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Roche Artemisinin Antimalarial Drugs Product Portfolios and Specifications
Table 121. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 122. Roche Main Business
Table 123. Roche Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artemisinin Antimalarial Drugs
Figure 2. Artemisinin Antimalarial Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Antimalarial Drugs Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Artemisinin Antimalarial Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Artemisinin Antimalarial Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Artesunate
Figure 10. Product Picture of Dihydroartemisinin
Figure 11. Product Picture of Artemether
Figure 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Type in 2022
Figure 13. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2018-2023)
Figure 14. Artemisinin Antimalarial Drugs Consumed in Prevention
Figure 15. Global Artemisinin Antimalarial Drugs Market: Prevention (2018-2023) & (KG)
Figure 16. Artemisinin Antimalarial Drugs Consumed in Treatment
Figure 17. Global Artemisinin Antimalarial Drugs Market: Treatment (2018-2023) & (KG)
Figure 18. Artemisinin Antimalarial Drugs Consumed in Other
Figure 19. Global Artemisinin Antimalarial Drugs Market: Other (2018-2023) & (KG)
Figure 20. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2022)
Figure 21. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application in 2022
Figure 22. Artemisinin Antimalarial Drugs Sales Market by Company in 2022 (KG)
Figure 23. Global Artemisinin Antimalarial Drugs Sales Market Share by Company in 2022
Figure 24. Artemisinin Antimalarial Drugs Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company in 2022
Figure 26. Global Artemisinin Antimalarial Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 29. Americas Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 30. APAC Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 31. APAC Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 32. Europe Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 33. Europe Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 35. Middle East & Africa Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country in 2022
Figure 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2022
Figure 38. Americas Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 39. Americas Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 40. United States Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region in 2022
Figure 45. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Regions in 2022
Figure 46. APAC Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 47. APAC Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 48. China Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country in 2022
Figure 56. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2022
Figure 57. Europe Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 58. Europe Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 59. Germany Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 68. Egypt Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs in 2022
Figure 74. Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
Figure 75. Industry Chain Structure of Artemisinin Antimalarial Drugs
Figure 76. Channels of Distribution
Figure 77. Global Artemisinin Antimalarial Drugs Sales Market Forecast by Region (2024-2029)
Figure 78. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Artemisinin Antimalarial Drugs
Figure 2. Artemisinin Antimalarial Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Antimalarial Drugs Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Artemisinin Antimalarial Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Artemisinin Antimalarial Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Artesunate
Figure 10. Product Picture of Dihydroartemisinin
Figure 11. Product Picture of Artemether
Figure 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Type in 2022
Figure 13. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2018-2023)
Figure 14. Artemisinin Antimalarial Drugs Consumed in Prevention
Figure 15. Global Artemisinin Antimalarial Drugs Market: Prevention (2018-2023) & (KG)
Figure 16. Artemisinin Antimalarial Drugs Consumed in Treatment
Figure 17. Global Artemisinin Antimalarial Drugs Market: Treatment (2018-2023) & (KG)
Figure 18. Artemisinin Antimalarial Drugs Consumed in Other
Figure 19. Global Artemisinin Antimalarial Drugs Market: Other (2018-2023) & (KG)
Figure 20. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2022)
Figure 21. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application in 2022
Figure 22. Artemisinin Antimalarial Drugs Sales Market by Company in 2022 (KG)
Figure 23. Global Artemisinin Antimalarial Drugs Sales Market Share by Company in 2022
Figure 24. Artemisinin Antimalarial Drugs Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company in 2022
Figure 26. Global Artemisinin Antimalarial Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 29. Americas Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 30. APAC Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 31. APAC Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 32. Europe Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 33. Europe Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Artemisinin Antimalarial Drugs Sales 2018-2023 (KG)
Figure 35. Middle East & Africa Artemisinin Antimalarial Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country in 2022
Figure 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2022
Figure 38. Americas Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 39. Americas Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 40. United States Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region in 2022
Figure 45. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Regions in 2022
Figure 46. APAC Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 47. APAC Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 48. China Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country in 2022
Figure 56. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2022
Figure 57. Europe Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 58. Europe Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 59. Germany Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Application (2018-2023)
Figure 68. Egypt Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Artemisinin Antimalarial Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs in 2022
Figure 74. Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
Figure 75. Industry Chain Structure of Artemisinin Antimalarial Drugs
Figure 76. Channels of Distribution
Figure 77. Global Artemisinin Antimalarial Drugs Sales Market Forecast by Region (2024-2029)
Figure 78. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Application (2024-2029)
